⌘K
Loading ticker…
REGENXBIO Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, REGENXBIO Inc. (RGNX) has a 3-month relative strength percentile of 78 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.7%, relative volume 2.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 78, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RGNX is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $12M notional. Top 3 carry $33M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $12M |
| XBIState Street SPDR S&P Biotech ETF | 0.15% | $11M |
| IWMiShares Russell 2000 ETF | 0.01% | $10M |
| VXFVanguard Extended Market ETF | 0.01% | $4M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $822K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RGNX Jan avg: -11.78% median: -10.08% win: 50% σ: 17.88% n: 4 2022-04-12 → 2026-05-29 | RGNX Feb avg: -0.04% median: -11.36% win: 25% σ: 28.58% n: 4 2022-04-12 → 2026-05-29 | RGNX Mar avg: 1.83% median: 0.76% win: 50% σ: 16.09% n: 4 2022-04-12 → 2026-05-29 | RGNX Apr avg: 1.53% median: 2.38% win: 60% σ: 22.62% n: 5 2022-04-12 → 2026-05-29 | RGNX May avg: -14.30% median: -11.00% win: 0% σ: 8.18% n: 5 2022-04-12 → 2026-05-29 | RGNX Jun avg: 1.93% median: 4.39% win: 50% σ: 17.68% n: 4 2022-04-12 → 2026-05-29 (current) | RGNX Jul avg: 11.88% median: 12.72% win: 75% σ: 15.03% n: 4 2022-04-12 → 2026-05-29 | RGNX Aug avg: -5.53% median: -6.40% win: 25% σ: 7.90% n: 4 2022-04-12 → 2026-05-29 | RGNX Sep avg: -5.88% median: -8.71% win: 25% σ: 9.74% n: 4 2022-04-12 → 2026-05-29 | RGNX Oct avg: -4.48% median: -14.28% win: 25% σ: 24.98% n: 4 2022-04-12 → 2026-05-29 | RGNX Nov avg: 18.19% median: 10.17% win: 100% σ: 23.00% n: 4 2022-04-12 → 2026-05-29 | RGNX Dec avg: -6.92% median: -6.57% win: 25% σ: 12.16% n: 4 2022-04-12 → 2026-05-29 |